KNSA

Kiniksa Pharmaceuticals International
KNSA

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.96B
EV
$1.70B
Shares Outstanding
77.50M
Beta
0.07

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$38.00
P/E 2025E
30.28x
P/Revenue 2025E
3.27x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Kiniksa Pharmaceuticals International, plc

gainify
KNSA

Kiniksa Pharmaceuticals International, plc

KNSA

Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its prod...

Sector

Healthcare

Industry

Biotechnology

CEO

Patel, Sanj

Employees

315

IPO Date

2018-05-25

Headquarters

23 Old Bond Street, Floor 3, London, Greater London, WIS 4PZ, United Kingdom

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on Threads
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.